Acta Med. 2026, 69: 55-64
https://doi.org/10.14712/18059694.2026.19
The Emerging Role and Clinical Impact of Vitamin D Supplementation in Breast Cancer Patients Undergoing Chemotherapy: A Systematic Review
References
1. J, Harper A, McCormack V, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025; 31(4): 1154–62.
<https://doi.org/10.1038/s41591-025-03502-3>
2. World Health Organization. Breast Cancer. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
3. Y, Agustina H, Abdurachman M, Achmad D. Breast Cancer in West Java: Where Do We Stand and Go? Indones J Cancer. 2020; 14(3): 91–6.
<https://doi.org/10.33371/ijoc.v14i3.737>
4. YX, Lim ZL, Ho PJ, Li J. Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives. Cancers (Basel). 2022; 14: 1–21.
5. SH, Prabandari YS, Bintoro BS, et al. Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study. PLoS One. 2022; 1–19.
6. T, Bhattacharya S, Gade K, Nasrazadani A, Brufsky AM. Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer. Breast Cancer (London). 2021; 13: 199–211.
7. T, Iwata H. Adjuvant and neoadjuvant therapy for breast cancer. Japanese J Clin Oncol. 2020; 50(January): 225–9.
<https://doi.org/10.1093/jjco/hyz213>
8. A, Joshi R. Improving chemotherapy outcome in early breast cancer. Gland Surg. 2019; 8(5): 585–7.
<https://doi.org/10.21037/gs.2019.08.04>
<PubMed>
9. B, Liu Q, Gai J, Guan J, Li Q. Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer. Comput Math Methods Med. 2021 Nov; 2021: 5440154.
10. AKM, Ibragimova KIE, Geurts SME, Bos MEMM, Erdkamp FLG, Tjan-heijnen VCG. The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice. Crit Rev Oncol Hematol. 2020; 153: 1–12.
<https://doi.org/10.1016/j.critrevonc.2020.102988>
11. SM, Pham AT, Nguyen LM, Cai H, Tran TV, Shu X. Chemotherapy-Induced Toxicities and Their Associations with Clinical and Non-Clinical Factors among Breast Cancer Patients in Vietnam. Curr Oncol. 2022; 29: 8269–84.
<https://doi.org/10.3390/curroncol29110653>
<PubMed>
12. M, Reinert T, Werutsky G, Zaffaroni F, Schwartsmann G. Health-related quality of life before and during chemotherapy in patients with early-stage breast cancer. Ecancer. 2020; 14: 1–11.
<https://doi.org/10.3332/ecancer.2020.1007>
<PubMed>
13. K, Pamula-Pilat J, Lanuszewska J, Butkiewicz D. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget. 2018; 9(10): 9114–36.
<https://doi.org/10.18632/oncotarget.24148>
<PubMed>
14. A, Malki A. Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications. Molecules. 2020; 25: 1–31.
15. A, Bustamante-Madrid P, Ferrer-Mayorga G, Barbáchano A, Larriba MJ, Muñoz A. Vitamin D Effects on Cell Differentiation and Stemness in Cancer. Cancers (Basel). 2020; 12: 1–19.
<https://doi.org/10.3390/cancers12092413>
<PubMed>
16. R, Dahiya K, Ahlawat R, Dahiya P, Singh S, Gupta K. A Review of the Role Portrayed by Vitamin D in Cancer. Cancer Ther Oncol. 2018; 11(2): 1–6.
17. MT, Shami A, Qarshi W, Shaheen R, Chaudari ZK, Shafiq M. Vitamin D Deficiency as Etiological Factor for Breast Cancer. Pakistan J Med Heal Sci. 2022; 16(08): 836–8.
<https://doi.org/10.53350/pjmhs22168836>
18. L, Butt ST, Borgquist S, et al. Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival. Nutrients. 2022; 14: 1–17.
<https://doi.org/10.3390/nu14163353>
<PubMed>
19. H, Sulistyoningrum DC, Witaningrum R, et al. Vitamin D status in breast cancer cases following chemotherapy: A pre and post observational study in a tertiary hospital in Yogyakarta, Indonesia. PLoS One. 2022; 17(6): e0270507.
<https://doi.org/10.1371/journal.pone.0270507>
<PubMed>
20. MS, Chimicoviaki J, Buttros DAB, et al. Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial. Nutr Cancer. 2025 Jul; 77(6): 648–57.
<https://doi.org/10.1080/01635581.2025.2480854>
21. E, Ordu C, Özmen T, et al. Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial. World J Surg. 2025 Jun; 49(6): 1396–405.
<https://doi.org/10.1002/wjs.12587>
<PubMed>
22. HF, Kadir AA, Srour M. The Effects of Omega-3 Fatty Acids and Vitamin D Supplementation on the Nutritional Status of Women with Breast Cancer in Palestine: An Open-Label Randomized Controlled Trial. Nutrients. 2024; 16: 3960.
<https://doi.org/10.3390/nu16223960>
<PubMed>
23. NA, Helmy MW, Hassan MAE, Khedr GA. The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy. Clin Breast Cancer. 2022 Jun; 22(4): 359–66.
<https://doi.org/10.1016/j.clbc.2022.01.008>
24. A, Rezaei M, Ehsani M, et al. Exploring the synergistic effects of vitamin D and synbiotics on cytokines profile, and treatment response in breast cancer: a pilot randomized clinical trial. Sci Rep. 2024 Sep; 14(1): 21372.
<https://doi.org/10.1038/s41598-024-72172-x>
<PubMed>
25. SB, Koru-Sengul T, Shah N, et al. Vitamin D Supplementation during Adjuvant Chemotherapy in Patients With HER2 þ Non-metastatic Breast Cancer. Clin Breast Cancer. 2015 Feb; 15(1): e1–11.
<https://doi.org/10.1016/j.clbc.2014.08.001>
26. VE. Cancer-associated malnutrition. Eur J Clin Nutr. 2018; 72(9): 1255–9.
<https://doi.org/10.1038/s41430-018-0245-4>
27. MAE. Use and effects of oral nutritional supplements in patients with cancer. Nutrition. 2019; 67–68: 110550.
<https://doi.org/10.1016/j.nut.2019.07.002>
28. C, Velleuer E. Vitamin D and the risk for cancer: A molecular analysis. Biochem Pharmacol. 2022; 196: 114735.
<https://doi.org/10.1016/j.bcp.2021.114735>
29. JL, Bours MJL, Roekel EH van, et al. Higher serum vitamin D concentrations are longitudinally associated with better global quality of life and less fatigue in colorectal cancer survivors up to 2 years after treatment. Cancer Epidemiol Biomarkers Prev. 2020; Jun; 29(6): 1135–44.
<https://doi.org/10.1158/1055-9965.EPI-19-1522>
30. M, Dusso A, Ariza G, Nabal M. Vitamin D deficiency and its association with fatigue and quality of life in advanced cancer patients under palliative care: A cross-sectional study. Palliat Med. 2016 Jan; 30(1): 89–96.
<https://doi.org/10.1177/0269216315601954>
31. C, Xun P, He K. Vitamin D supplementation and quality of life following diagnosis in stage II colorectal cancer patients: a 24-month prospective study. Support Care Cancer. 2016; 24(4): 1655–61.
32. K, Sugiura T, Yamashita F, Matsushima H, Hishida A. Supplementation with Alfacalcidol increases protein intake and serum albumin concentration in patients undergoing hemodialysis with hpoalbumineamia. Blood Purif. 2004; 22(2): 210–5.
<https://doi.org/10.1159/000076855>
33. Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J Biol Chem. 2013 Jul; 288(27): 19450–8.
<https://doi.org/10.1074/jbc.M113.467670>
<PubMed>
34. AK. The Anti-Inflammatory Roles of Vitamin D for Improving Human Health. Curr Issues Mol Biol. 2024 Nov; 46(12): 13514–25.
<https://doi.org/10.3390/cimb46120807>
<PubMed>
35. V, Popov V. Vitamin D levels in patients with non-Hodgkin lymphoma/diffuse large B-cell lymphoma, chronic lymphocytic leukemia and multiple myeloma. J Int Med Res. 2020 Jul; 48(7): 300060520943421.
<https://doi.org/10.1177/0300060520943421>
<PubMed>
36. V, Sirbu O, Lionte C, et al. The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity. Life. 2022; 12(1183): 1–18.
<https://doi.org/10.3390/life12081183>
<PubMed>
37. JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012 Jan; 441(1): 61–76.
<https://doi.org/10.1042/BJ20110744>
<PubMed>
38. Jeon S. Exploring vitamin D metabolism and function in cancer. Exp Mol Med [Internet]. 2018; Available from.
<https://doi.org/10.1038/s12276-018-0038-9>
<PubMed>
39. J. Vitamin D and Breast Cancer: Mechanistic Update. JBMR Plus. 2021; 5(12): e10582.
<https://doi.org/10.1002/jbm4.10582>
<PubMed>
40. F, Tang MJ, Tai IT. Synergism between vitamin D and secreted protein acidic and rich in cysteine – induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy. Mol Cancer Ther. 2007; 6: 309–17.
<https://doi.org/10.1158/1535-7163.MCT-06-0517>
41. H, Walter V, Jansen L, et al. Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis. Nutrients. 2018 Jul; 10(7): 896.
<https://doi.org/10.3390/nu10070896>
<PubMed>
42. ML, Capelas ML, Pimenta NM, et al. A Systematic Review of Vitamin D Supplementation in Oncology: Chance of Science or Effectiveness? Nutrients. 2025 Feb 11; 17(4): 634.
<https://doi.org/10.3390/nu17040634>
<PubMed>


